Our 20-Year Institutional Experience with Surgical Approach for Breast Hamartomas.

Zeliha Türkyılmaz, Tahacan Aydın, R. Yılmaz, Semen Önder, E. Özkurt, M. Tükenmez, M. Müslümanoğlu, G. Acunaş, A. Igci, V. Özmen, A. Dinçağ, N. Cabioğlu
{"title":"Our 20-Year Institutional Experience with Surgical Approach for Breast Hamartomas.","authors":"Zeliha Türkyılmaz, Tahacan Aydın, R. Yılmaz, Semen Önder, E. Özkurt, M. Tükenmez, M. Müslümanoğlu, G. Acunaş, A. Igci, V. Özmen, A. Dinçağ, N. Cabioğlu","doi":"10.5152/ejbh.2019.4624","DOIUrl":null,"url":null,"abstract":"Objective\nHamartomas are rare, slowly-growing breast tumours. Clinical, radiological and histopathological examination together increase the diagnostic accuracy. To evaluate the clinicopathologic features of hamartomas and outline our clinical approach to hamartomas in our 20-year experience at our Breast Clinic.\n\n\nMaterials and Methods\nBetween 1995 and 2015, 24 cases were retrospectively analyzed with a diagnosis of breast hamartoma at our Breast Clinic followed by excisional biopsy. Data was obtained on patient demographics, clinical examination, radiological findings and histopathological subtypes.\n\n\nResults\nOf 1338 benign breast tumours excised from January 1995 to January 2015, 24 (1.8%) were identified as breast hamartoma. Median age of patients was 42 (range, 13-70), whereas the median tumour size was 5 cm (1-10 cm). On preoperative imaging, hamartoma was most commonly misdiagnosed as fibroadenoma. Pathological examination of the 24 biopsy specimens revealed 3 cases with pseudoangiomatous stromal hyperplasia, and another hamartoma associated with a radial scar within the centre of the lesion. Of those, one patient was diagnosed with malignant phylloides tumour in the same breast. At a median follow-up 58.4 months, none of the patients recurred or developed malignancy.\n\n\nConclusion\nHamartomas can often be missed by clinicians, due to its benign nature which is poorly understood. Despite their slow growth, hamartomas can reach large sizes and can cause breast asymmetry. Although it is rare, hamartoma can be seen along with malignancy, as it is formed from similar components of breast tissue. Therefore, careful diagnosis and appropriate management including surgery are required.","PeriodicalId":91975,"journal":{"name":"The journal of breast health","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The journal of breast health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5152/ejbh.2019.4624","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 6

Abstract

Objective Hamartomas are rare, slowly-growing breast tumours. Clinical, radiological and histopathological examination together increase the diagnostic accuracy. To evaluate the clinicopathologic features of hamartomas and outline our clinical approach to hamartomas in our 20-year experience at our Breast Clinic. Materials and Methods Between 1995 and 2015, 24 cases were retrospectively analyzed with a diagnosis of breast hamartoma at our Breast Clinic followed by excisional biopsy. Data was obtained on patient demographics, clinical examination, radiological findings and histopathological subtypes. Results Of 1338 benign breast tumours excised from January 1995 to January 2015, 24 (1.8%) were identified as breast hamartoma. Median age of patients was 42 (range, 13-70), whereas the median tumour size was 5 cm (1-10 cm). On preoperative imaging, hamartoma was most commonly misdiagnosed as fibroadenoma. Pathological examination of the 24 biopsy specimens revealed 3 cases with pseudoangiomatous stromal hyperplasia, and another hamartoma associated with a radial scar within the centre of the lesion. Of those, one patient was diagnosed with malignant phylloides tumour in the same breast. At a median follow-up 58.4 months, none of the patients recurred or developed malignancy. Conclusion Hamartomas can often be missed by clinicians, due to its benign nature which is poorly understood. Despite their slow growth, hamartomas can reach large sizes and can cause breast asymmetry. Although it is rare, hamartoma can be seen along with malignancy, as it is formed from similar components of breast tissue. Therefore, careful diagnosis and appropriate management including surgery are required.
我们在乳房错构瘤手术治疗方面的20年机构经验。
目的错构瘤是一种罕见的生长缓慢的乳腺肿瘤。临床、放射学和组织病理学检查共同提高了诊断的准确性。评估错构瘤的临床病理特征,并概述我们在乳腺诊所20年的经验错构瘤的临床方法。材料与方法回顾性分析1995年至2015年在我院乳腺门诊诊断为乳腺错构瘤并行切除活检的24例病例。获得了患者人口统计学、临床检查、放射学表现和组织病理学亚型的数据。结果1995年1月至2015年1月,1338例乳腺良性肿瘤中,24例(1.8%)为乳腺错构瘤。患者的中位年龄为42岁(范围13-70岁),而中位肿瘤大小为5厘米(1-10厘米)。在术前影像学上,错构瘤最常被误诊为纤维腺瘤。24例活检标本病理检查显示3例为假性血管瘤间质增生,另一例错构瘤伴病灶中心放射状瘢痕。其中,一名患者在同一乳房被诊断为恶性叶状瘤。在中位随访58.4个月时,没有患者复发或发展为恶性肿瘤。结论错构瘤是一种良性肿瘤,临床医师对其了解甚少,容易漏诊。尽管它们生长缓慢,但错构瘤可以达到很大的尺寸,并可能导致乳房不对称。虽然它是罕见的,但错构瘤可以与恶性肿瘤一起出现,因为它是由乳房组织的相似成分形成的。因此,需要仔细诊断和适当的治疗,包括手术。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信